Pfizer CEO rules out generic COVID drug Paxlovid for China
Jan 9 (Reuters) – Pfizer Inc (PFE.N) is not in talks with Chinese authorities to allow a generic version of its COVID-19 treatment Paxlovid to be used there, but is in discussion on the price of the product brand, said the general manager. said Albert Bourla on Monday. Reuters reported on Friday that China was …
Pfizer CEO rules out generic COVID drug Paxlovid for China Read More »